Effects of astrocyte-targeted production of interleukin-6 in the mouse on the host response to nerve injury

GLIA

Volumn 62, Issue 7, 2014, Pages 1142-1161

  Almolda, Beatriz ^a   Villacampa, Nàdia ^a   Manders, Peter ^b   Hidalgo, Juan ^a   Campbell, Iain L ^b   González, Berta ^a   Castellano, Bernardo ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CD44; Facial nerve axotomy; Lymphocytes; Microglia; Osteopontin; Transgenic animal

Indexed keywords

ALPHA5 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; HERMES ANTIGEN; INTEGRIN; INTERLEUKIN 6; OSTEOPONTIN; CD44 PROTEIN, MOUSE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; INTERLEUKIN-6, MOUSE; NERVE PROTEIN; SPP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FACIAL NERVE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MICROGLIA; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NERVE INJURY; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE; ANIMAL; CELL DEATH; DISEASE MODEL; FACIAL NERVE INJURY; GENETICS; GLIA; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD18; ANTIGENS, CD44; ASTROCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; DISEASE MODELS, ANIMAL; FACIAL NERVE INJURIES; INTEGRIN ALPHA5; INTEGRINS; INTERLEUKIN-6; LYMPHOCYTES; MICE, TRANSGENIC; MICROGLIA; MOTOR NEURONS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; OSTEOPONTIN;

EID: 84900825793     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22668     Document Type: Article

References (94)

1. Abercrombie M. 1946. Estimation of nuclear population from microtome sections. Anat Rec 94:239-247.
2. Almolda B, Costa M, Montoya M, Gonzalez B, Castellano B. 2009. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model. J Neuroimmunol 209:65-80.
3. Almolda B, Costa M, Montoya M, Gonzalez B, Castellano B. 2011. Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat. PLoS One 6:e27473.
4. Almolda B, Gonzalez B, Castellano B. 2010. Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE. J Neuroimmunol 223:39-54.
5. Almolda B, Gonzalez B, Castellano B. 2013. Microglia detection by enzymatic histochemistry. Methods Mol Biol 1041:243-259.
6. Benveniste EN. 1998. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 9:259-275.
7. Blinzinger K, Kreutzberg G. 1968. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat 85:145-157.
8. Borges K, Gearing M, Rittling S, Sorensen ES, Kotloski R, Denhardt DT, Dingledine R. 2008. Characterization of osteopontin expression and function after status epilepticus. Epilepsia 49:1675-1685.
9. Brunello AG, Weissenberger J, Kappeler A, Vallan C, Peters M, Rose-John S, Weis J. 2000. Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice. Am J Pathol 157:1485-1493.
10. Byram SC, Carson MJ, Deboy CA, Serpe CJ, Sanders VM, Jones KJ. 2004. CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24:4333-4339.
11. Campbell IL. 1998. Transgenic mice and cytokine actions in the brain: Bridging the gap between structural and functional neuropathology. Brain Res Brain Res Rev 26:327-336.
12. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065.
13. Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, Siddiq M, Martinez J, Spencer T, Carmel J, Hart RB, Filbin MT. 2006. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci 26:5565-5573.
14. Carecchio M, Comi C. 2011. The role of osteopontin in neurodegenerative diseases. J Alzheimers Dis 25:179-185.
15. Castellano B, Gonzalez B, Dalmau I, Vela JM. 1991. Identification and distribution of microglial cells in the cerebral cortex of the lizard: A histochemical study. J Comp Neurol 311:434-444.
16. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294:1731-1735.
17. Chiang CS, Stalder A, Samimi A, Campbell IL. 1994. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice. Dev Neurosci 16:212-221.
18. Choi JS, Kim HY, Cha JH, Choi JY, Lee MY. 2007. Transient microglial and prolonged astroglial upregulation of osteopontin following transient forebrain ischemia in rats. Brain Res 1151:195-202.
19. Conroy SM, Nguyen V, Quina LA, Blakely-Gonzales P, Ur C, Netzeband JG, Prieto AL, Gruol DL. 2004. Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures. J Neuroimmunol 155:43-54.
20. Dauer DJ, Huang Z, Ha GK, Kim J, Khosrowzadeh D, Petitto JM. 2011. Age and facial nerve axotomy-induced T cell trafficking: Relation to microglial and motor neuron status. Brain Behav Immun 25:77-82.
21. Deboy CA, Xin J, Byram SC, Serpe CJ, Sanders VM, Jones KJ. 2006. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells. Exp Neurol 201:212-224.
22. Erta M, Quintana A, Hidalgo J. 2012. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8:1254-1266.
23. Fisher J, Mizrahi T, Schori H, Yoles E, Levkovitch-Verbin H, Haggiag S, Revel M, Schwartz M. 2001. Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility. J Neuroimmunol 119:1-9.
24. Fu Y, Hashimoto M, Ino H, Murakami M, Yamazaki M, Moriya H. 2004. Spinal root avulsion-induced upregulation of osteopontin expression in the adult rat spinal cord. Acta Neuropathol 107:8-16.
25. Gadient RA, Otten UH. 1997. Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials. Prog Neurobiol 52:379-390.
26. Galiano M, Liu ZQ, Kalla R, Bohatschek M, Koppius A, Gschwendtner A, Xu S, Werner A, Kloss CU, Jones LL, Bluethmann H, Raivich G. 2001. Interleukin-6 (IL6) and cellular response to facial nerve injury: Effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur J Neurosci 14:327-341.
27. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. 1998. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358.
28. Giralt M, Ramos R, Quintana A, Ferrer B, Erta M, Castro-Freire M, Comes G, Sanz E, Unzeta M, Pifarre P, Garcia A, Campbell IL, Hidalgo J. 2013. Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6. Glia 61:587-600.
29. Gruol DL, Nelson TE. 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15:307-339.
30. Ha GK, Huang Z, Streit WJ, Petitto JM. 2006. Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: Effect of genetic background and the RAG2 gene. J Neuroimmunol 172:1-8.
31. Ha GK, Parikh S, Huang Z, Petitto JM. 2008. Influence of injury severity on the rate and magnitude of the T lymphocyte and neuronal response to facial nerve axotomy. J Neuroimmunol 199:18-23.
32. Hao HP, Doh-Ura K, Nakanishi H. 2007. Impairment of microglial responses to facial nerve axotomy in cathepsin S-deficient mice. J Neurosci Res 85:2196-2206.
33. Hashimoto M, Koda M, Ino H, Murakami M, Yamazaki M, Moriya H. 2003. Upregulation of osteopontin expression in rat spinal cord microglia after traumatic injury. J Neurotrauma 20:287-296.
34. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. 1997. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 94:1500-1505.
35. Iczkiewicz J, Rose S, Jenner P. 2005. Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat. Eur J Neurosci 21:1911-1920.
36. Ikeda K, Iwasaki Y, Shiojima T, Kinoshita M. 1996. Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy. J Neurol Sci 135:109-113.
37. Jin JK, Na YJ, Moon C, Kim H, Ahn M, Kim YS, Shin T. 2006. Increased expression of osteopontin in the brain with scrapie infection. Brain Res 1072:227-233.
38. Jones KJ, Serpe CJ, Byram SC, Deboy CA, Sanders VM. 2005. Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury. Brain Behav Immun 19:12-9.
39. Jones LL, Kreutzberg GW, Raivich G. 1997. Regulation of CD44 in the regenerating mouse facial motor nucleus. Eur J Neurosci 9:1854-1863.
40. Kalla R, Liu Z, Xu S, Koppius A, Imai Y, Kloss CU, Kohsaka S, Gschwendtner A, Moller JC, Werner A, Raivich G. 2001. Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: Impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice. J Comp Neurol 436:182-201.
41. Kazanecki CC, Uzwiak DJ, Denhardt DT. 2007. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 102:912-924.
42. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
43. Kim SY, Choi YS, Choi JS, Cha JH, Kim ON, Lee SB, Chung JW, Chun MH, Lee MY. 2002. Osteopontin in kainic acid-induced microglial reactions in the rat brain. Mol Cells 13:429-435.
44. Kimura A, Kishimoto T. 2010. IL-6: Regulator of Treg/Th17 balance. Eur J Immunol 40:1830-1835.
45. Kishimoto T. 2006. Interleukin-6: Discovery of a pleiotropic cytokine. Arthritis Res Ther 8 (Suppl 2):S2.
46. Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
47. Klein MA, Moller JC, Jones LL, Bluethmann H, Kreutzberg GW, Raivich G. 1997. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19:227-233.
48. Kloss CU, Kreutzberg GW, Raivich G. 1997. Proliferation of ramified microglia on an astrocyte monolayer: Characterization of stimulatory and inhibitory cytokines. J Neurosci Res 49:248-254.
49. Kloss CU, Werner A, Klein MA, Shen J, Menuz K, Probst JC, Kreutzberg GW, Raivich G. 1999. Integrin family of cell adhesion molecules in the injured brain: Regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. J Comp Neurol 411:162-178.
50. Krady JK, Lin HW, Liberto CM, Basu A, Kremlev SG, Levison SW. 2008. Ciliary neurotrophic factor and interleukin-6 differentially activate microglia. J Neurosci Res 86:1538-1547.
51. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
52. Lacroix S, Chang L, Rose-John S, Tuszynski MH. 2002. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J Comp Neurol 454:213-228.
53. Lee JY, Choi JS, Choi JY, Shin YJ, Yun H, Cha JH, Chun MH, Lee MY. 2010. Spatial and temporal changes of osteopontin in oxygen-glucose-deprived hippocampal slice cultures. Acta Neurobiol Exp (Wars) 70:1-12.
54. Loddick SA, Turnbull AV, Rothwell NJ. 1998. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18:176-179.
55. Makwana M, Jones LL, Cuthill D, Heuer H, Bohatschek M, Hristova M, Friedrichsen S, Ormsby I, Bueringer D, Koppius A, Bauer K, Doetschman T, Raivich G. 2007. Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS. J Neurosci 27:11201-11213.
56. Makwana M, Werner A, Acosta-Saltos A, Gonitel R, Pararajasingham A, Ruff C, Rumajogee P, Cuthill D, Galiano M, Bohatschek M, Wallace AS, Anderson PN, Mayer U, Behrens A, Raivich G. 2010. Peripheral facial nerve axotomy in mice causes sprouting of motor axons into perineuronal central white matter: Time course and molecular characterization. J Comp Neurol 518:699-721.
57. Milner R, Campbell IL. 2006. Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system. Mol Cell Neurosci 33:429-440.
58. Moran LB, Graeber MB. 2004. The facial nerve axotomy model. Brain Res Brain Res Rev 44:154-178.
59. Mukaino M, Nakamura M, Yamada O, Okada S, Morikawa S, Renault-Mihara F, Iwanami A, Ikegami T, Ohsugi Y, Tsuji O, Katoh H, Matsuzaki Y, Toyama Y, Liu M, Okano H. 2010. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 224:403-414.
60. Murabe Y, Sano Y. 1981. Morphological studies on neuroglia. I. Electron microscopic identification of silver-impregnated glial cells. Cell Tissue Res 216:557-568.
61. Murphy PG, Borthwick LS, Johnston RS, Kuchel G, Richardson PM. 1999. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J Neurosci 19:3791-3800.
62. Nakamura M, Okada S, Toyama Y, Okano H. 2005. Role of IL-6 in spinal cord injury in a mouse model. Clin Rev Allergy Immunol 28:197-204.
63. Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, Iwamoto Y, Yoshizaki K, Kishimoto T, Toyama Y, Okano H. 2004. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 76:265-276.
64. Pekny M, Wilhelmsson U, Pekna M. 2014. The dual role of astrocyte activation and reactive gliosis. Neurosci Lett S0304-3940(14):00008-00001.
65. Petito CK, Adkins B, Mccarthy M, Roberts B, Khamis I. 2003. CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J Neurovirol 9:36-44.
66. Quintana A, Erta M, Ferrer B, Comes G, Giralt M, Hidalgo J. 2013. Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav Immun 27:162-173.
67. Quintana A, Muller M, Frausto RF, Ramos R, Getts DR, Sanz E, Hofer MJ, Krauthausen M, King NJ, Hidalgo J, Campbell IL. 2009. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 183:2079-2088.
68. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77-105.
69. Raivich G, Jones LL, Kloss CU, Werner A, Neumann H, Kreutzberg GW. 1998. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 18:5804-5816.
70. Raivich G, Moreno-Flores MT, Moller JC, Kreutzberg GW. 1994. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur J Neurosci 6:1615-1618.
71. Sander LE, Obermeier F, Dierssen U, Kroy DC, Singh AK, Seidler U, Streetz KL, Lutz HH, Muller W, Tacke F, Trautwein C. 2008. Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation. J Immunol 181:3586-3594.
72. Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Baron Van Evercooren A, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U. 2004. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci 25:707-721.
73. Serpe CJ, Kohm AP, Huppenbauer CB, Sanders VM, Jones KJ. 1999. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J Neurosci 19:RC7.
74. Serpe CJ, Sanders VM, Jones KJ. 2000. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J Neurosci Res 62:273-278.
75. Shin SL, Cha JH, Chun MH, Chung JW, Lee MY. 1999. Expression of osteopontin mRNA in the adult rat brain. Neurosci Lett 273:73-76.
76. Shin T, Ahn M, Kim H, Moon C, Kang TY, Lee JM, Sim KB, Hyun JW. 2005. Temporal expression of osteopontin and CD44 in rat brains with experimental cryolesions. Brain Res 1041:95-101.
77. Shin T, Koh CS. 2004. Immunohistochemical detection of osteopontin in the spinal cords of mice with Theiler's murine encephalomyelitis virus-induced demyelinating disease. Neurosci Lett 356:72-74.
78. Sinclair C, Mirakhur M, Kirk J, Farrell M, Mcquaid S. 2005. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: An immunohistochemical study utilizing tissue microarrays. Neuropathol Appl Neurobiol 31:292-303.
79. Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, Gerlo S. 2011. Interleukin-6, a mental cytokine. Brain Res Rev 67:157-183.
80. Stanke M, Duong CV, Pape M, Geissen M, Burbach G, Deller T, Gascan H, Otto C, Parlato R, Schutz G, Rohrer H. 2006. Target-dependent specification of the neurotransmitter phenotype: Cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development 133:141-150.
81. Suzuki S, Tanaka K, Suzuki N. 2009. Ambivalent aspects of interleukin-6 in cerebral ischemia: Inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 29:464-479.
82. Suzuki T, Sato T, Ichikawa H. 2012. Osteocalcin- and osteopontin-containing neurons in the rat hind brain. Cell Mol Neurobiol 32:1265-1273.
83. Svensson M, Aldskogius H. 1993. Synaptic density of axotomized hypoglossal motorneurons following pharmacological blockade of the microglial cell proliferation. Exp Neurol 120:123-131.
84. Swartz KR, Liu F, Sewell D, Schochet T, Campbell I, Sandor M, Fabry Z. 2001. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 896:86-95.
85. Taga T, Kishimoto T. 1997. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819.
86. Tilgner J, Volk B, Kaltschmidt C. 2001. Continuous interleukin-6 application in vivo via macroencapsulation of interleukin-6-expressing COS-7 cells induces massive gliosis. Glia 35:234-245.
87. Trapp BD, Wujek JR, Criste GA, Jalabi W, Yin X, Kidd GJ, Stohlman S, Ransohoff R. 2007. Evidence for synaptic stripping by cortical microglia. Glia 55:360-368.
88. van Horssen J, Singh S, van der Pol S, Kipp M, Lim JL, Peferoen L, Gerritsen W, Kooi EJ, Witte ME, Geurts JJ, de Vries HE, Peferoen-Baert R, van den Elsen PJ, van der Valk P, Amor S. 2012. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation 9:156.
89. Van Wagoner NJ, Benveniste EN. 1999. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 100:124-139.
90. Villacampa N, Almolda B, Gonzalez B, Castellano B. 2013. Tomato lectin histochemistry for microglial visualization. Methods Mol Biol 1041:261-279.
91. Weber GF, Ashkar S, Glimcher MJ, Cantor H. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
92. Werner A, Kloss CU, Walter J, Kreutzberg GW, Raivich G. 1998. Intercellular adhesion molecule-1 (ICAM-1) in the mouse facial motor nucleus after axonal injury and during regeneration. J Neurocytol 27:219-232.
93. Wung JK, Perry G, Kowalski A, Harris PL, Bishop GM, Trivedi MA, Johnson SC, Smith MA, Denhardt DT, Atwood CS. 2007. Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Curr Alzheimer Res 4:67-72.
94. Zhong J, Dietzel ID, Wahle P, Kopf M, Heumann R. 1999. Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J Neurosci 19:4305-4313.